Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Solid Neoplasms × Fluorouracil × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 26 Pancreatic Neoplasms 23 Rectal Neoplasms 13 Esophageal Neoplasms 12 Colonic Neoplasms 11 Stomach Neoplasms 8 Esophageal Squamous Cell Carcinoma 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Adenocarcinoma Of Esophagus 6 Head and Neck Neoplasms 5 Gastrointestinal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Neoplasms 3 Liver Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Hepatocellular 3 Biliary Tract Neoplasms 3 Advanced Solid Tumors 3 Advanced Solid Tumor 3 Adenocarcinoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Melanoma 2 Kidney Neoplasms 2 Advanced Malignant Tumors 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC 1 Solid Neoplasms 1 Solid Cancer 1

Interventions

pembrolizumab 1 Platinum 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04420884 2025-06-13

iintune-1

Takeda

Phase 1/2 Active not recruiting

Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡